Class IIIOngoing

AcetaZOLAMIDE Tablets recall

FDA recall D-0659-2024 · initiated Aug 24, 2024

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Discoloration

Details

Product: AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
Recalling company: Rubicon Research Private Limited
Classification: Class III
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide in the US
Initiated: Aug 24, 2024
FDA report date: Sep 25, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0659-2024 ↗

← All drug recalls